Potier, Marie-Claude; Pierce, Jon; Hilgenkamp, Thessa; Stagni, Fiorenza; Emili, Marco; Wiseman, Frances; Roper, Randall; Carmona-Iragui, María; Rebillat, Anne-Sophie; Barone, Eugenio; Perluigi, Marzia; Skotko, Brian; Zaman, Shahid; Sullivan, Kelly; Rozen, Esteban; Granholm-Bentley, Ann-Charlotte; Bartesaghi, Renata; Mobley, William; Delabar, Jean-Maurice; Dierssen, Mara; Reeves, Roger; Strydom, Andre, Advocating for increased awareness and research on Down syndrome, «LANCET NEUROLOGY», 2025, 24, pp. 288 - 288 [Comment or similar]
Emili, Marco; Stagni, Fiorenza; Guidi, Sandra; Russo, Carla; Chevalier, Claire; Duchon, Arnaud; Herault, Yann; Bartesaghi, Renata, Dendritic phenotype and proliferation potency in the hippocampal dentate
gyrus of the Ts66Yah model of Down syndrome, «NEUROSCIENCE LETTERS», 2025, 850, pp. 1 - 7 [Scientific article]
Emili M.; Stagni F.; Bonasoni M.P.; Guidi S.; Bartesaghi R., Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome, «DEVELOPMENTAL NEUROBIOLOGY», 2024, 2024, pp. 1 - 10 [Scientific article]
Coordination of a Research Project: Effect of adolescent treatment with the flavonoid 7,8-DHF on brain wiring, synaptic plasticity and cognitive performance in a model of Down syndrome.
Ravaioli F.; Stagni F.; Guidi S.; Pirazzini C.; Garagnani P.; Silvani A.; Zoccoli G.; Bartesaghi R.; Bacalini M.G., Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome, «FRONTIERS IN AGING NEUROSCIENCE», 2024, 16, Article number: 1401109 , pp. 1 - 5 [Scientific article]Open Access
Emili M.; Stagni F.; Russo C.; Angelozzi L.; Guidi S.; Bartesaghi R., Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model, «NEUROPHARMACOLOGY», 2024, 261, pp. 1 - 18 [Scientific article]
Uguagliati, Beatrice; Stagni, Fiorenza; Emili, Marco; Giacomini, Andrea; Russo, Carla; Guidi, Sandra; Bartesaghi, Renata, Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome, «DEVELOPMENTAL NEUROSCIENCE», 2022, 44, pp. 23 - 38 [Scientific article]Open Access
Valenti D.; Stagni F.; Emili M.; Guidi S.; Bartesaghi R.; Vacca R.A., Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone, «ANTIOXIDANTS», 2022, 11, Article number: 62 , pp. 1 - 14 [Scientific article]Open Access
Stagni, Fiorenza; Bartesaghi, Renata, The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives, «FRONTIERS IN CELLULAR NEUROSCIENCE», 2022, 16, Article number: 903729 , pp. 1 - 31 [Scientific article]Open Access
Emili M.; Guidi S.; Uguagliati B.; Giacomini A.; Bartesaghi R.; Stagni F., Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders, «CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION», 2022, 62, pp. 13 - 50 [Scientific article]Open Access
Uguagliati B.; Al-Absi A.-R.; Stagni F.; Emili M.; Giacomini A.; Guidi S.; Nyengaard J.R.; Bartesaghi R., Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome, «HIPPOCAMPUS», 2021, 31, pp. 435 - 447 [Scientific article]
Stagni F.; Guidi S.; Bartesaghi R., Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome, in: Factors Affecting Neurodevelopment. Genetics, Neurology, Behavior, and Diet, Amsterdam, Elsevier, 2021, pp. 619 - 630 [Chapter or essay]
Bartolucci M.L.; Berteotti C.; Alvente S.; Bastianini S.; Guidi S.; Lo Martire V.; Matteoli G.; Silvani A.; Stagni F.; Bosi M.; Alessandri-Bonetti G.; Bartesaghi R.; Zoccoli G., Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome, «NEUROBIOLOGY OF DISEASE», 2021, 159, Article number: 105508 , pp. 1 - 9 [Scientific article]Open Access
Stagni F.; Uguagliati B.; Emili M.; Giacomini A.; Bartesaghi R.; Guidi S., The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome, «SCIENTIFIC REPORTS», 2021, 11, Article number: 6300 , pp. 1 - 21 [Scientific article]Open Access
Marco Emili, Fiorenza Stagni, Maria Elisa Salvalai, Beatrice Uguagliati, Andrea Giacomini, Christelle Albac, Marie-Claude Potier, Mariagrazia Grilli, Renata Bartesaghi, Sandra Guidi, Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome, «NEUROBIOLOGY OF DISEASE», 2020, 140, Article number: 104874 , pp. 1 - 19 [Scientific article]Open Access
